Clinical Trial Update: Efficacy and Safety Study of Tafenoquine (TQ) Co-administered With Dihydroartemisinin-piperaquine (DHA-PQP) for the Radical Cure of Plasmodium Vivax (P. Vivax) Malaria [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating tafenoquine co-administered with dihydroartemisinin-piperaquine for radical cure of Plasmodium vivax malaria has completed with results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malaria
• Plasmodium Vivax Malaria

Drugs mentioned

• Dihydroartemisinin-piperaquine (dihydroartemisinin-piperaquine)
• Tafenoquine (tafenoquine)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Malaria, Vivax | Phase 3 | Status: COMPLETED | Results posted: 2020-07-24